FY2025 Earnings Forecast for USNA Issued By DA Davidson

USANA Health Sciences, Inc. (NYSE:USNA - Free Report) - Equities researchers at DA Davidson issued their FY2025 earnings estimates for USANA Health Sciences in a research report issued to clients and investors on Tuesday, February 25th. DA Davidson analyst C. Xue forecasts that the company will post earnings of $2.57 per share for the year. DA Davidson currently has a "Neutral" rating and a $36.00 target price on the stock. The consensus estimate for USANA Health Sciences' current full-year earnings is $2.45 per share. DA Davidson also issued estimates for USANA Health Sciences' FY2026 earnings at $2.68 EPS.

USANA Health Sciences (NYSE:USNA - Get Free Report) last released its quarterly earnings results on Tuesday, February 25th. The company reported $0.64 earnings per share for the quarter, beating the consensus estimate of $0.49 by $0.15. The firm had revenue of $213.61 million for the quarter, compared to analysts' expectations of $208.82 million. USANA Health Sciences had a return on equity of 10.64% and a net margin of 6.30%.

Several other equities research analysts have also commented on USNA. StockNews.com lowered shares of USANA Health Sciences from a "strong-buy" rating to a "buy" rating in a research report on Friday, February 14th. Sidoti downgraded shares of USANA Health Sciences from a "strong-buy" rating to a "hold" rating in a research report on Tuesday, February 18th.

Remove Ads

USANA Health Sciences Trading Up 3.2 %

USNA stock traded up $0.91 during trading on Thursday, reaching $29.55. The stock had a trading volume of 299,854 shares, compared to its average volume of 166,624. The firm has a market cap of $563.22 million, a PE ratio of 10.44, a PEG ratio of 0.93 and a beta of 0.87. The stock's 50 day moving average is $33.42 and its two-hundred day moving average is $36.49. USANA Health Sciences has a 52 week low of $27.71 and a 52 week high of $50.32.

Institutional Inflows and Outflows

Several institutional investors have recently made changes to their positions in USNA. R Squared Ltd purchased a new stake in USANA Health Sciences in the 4th quarter worth approximately $28,000. Safe Harbor Fiduciary LLC bought a new position in shares of USANA Health Sciences in the third quarter worth approximately $30,000. KBC Group NV increased its stake in shares of USANA Health Sciences by 96.6% in the third quarter. KBC Group NV now owns 1,056 shares of the company's stock worth $40,000 after purchasing an additional 519 shares in the last quarter. KLP Kapitalforvaltning AS bought a new stake in shares of USANA Health Sciences during the 4th quarter valued at $83,000. Finally, Quantbot Technologies LP purchased a new position in shares of USANA Health Sciences during the 4th quarter valued at $132,000. Institutional investors own 54.25% of the company's stock.

USANA Health Sciences Company Profile

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.